The four parathyroid glands are small, button-shaped endocrine organs located in the neck, typically on the posterior surface of the thyroid gland. Each gland weighs approximately 30-50 milligrams and measures 6mm in length. Their yellow-brown color distinguishes them from the darker thyroid tissue.

These glands contain chief cells—specialized endocrine cells that produce and secrete parathyroid hormone. The glands receive their blood supply from the inferior thyroid arteries and have rich vascular networks essential for their function.

Skeletal System

Hyperparathyroidism profoundly affects bone metabolism through increased osteoclast activity. Bone resorption accelerates, releasing calcium and phosphate into the bloodstream. This leads to:

• Osteoporosis: Progressive loss of bone mineral density, particularly affecting the lumbar spine and hip
• Osteitis Fibrosa Cystica: Severe bone disease with cystic lesions, historically seen in advanced cases
• Bone Pain: Deep, aching pain in bones and joints
• Increased Fracture Risk: Fragile bones break more easily, even with minor trauma
• Bone Deformities: In severe, long-standing cases

Renal System

The kidneys bear significant burden from hyperparathyroidism:

• Nephrolithiasis (Kidney Stones): Excess calcium is excreted in urine, forming calcium oxalate or calcium phosphate stones
• Nephrocalcinosis: Calcium deposition in kidney tissue itself
• Polyuria: Increased urination from kidney's inability to concentrate urine
• Chronic Kidney Disease: Progressive kidney damage from stones and calcification
• Renal Colic: Severe flank pain when stones pass through urinary tract

Cardiovascular System

Cardiovascular manifestations include:

• Hypertension: High blood pressure affects 30-50% of patients
• Vascular Calcification: Calcium deposits in blood vessel walls
• Cardiac Valvular Calcification: Calcium on heart valves
• Arrhythmias: Electrical conduction abnormalities
• Accelerated Atherosclerosis: Increased cardiovascular disease risk

Neuromuscular System

Neuromuscular symptoms significantly impact quality of life:

• Fatigue: Persistent, unexplained exhaustion
• Muscle Weakness: Particularly affecting proximal muscles
• Depression: Low mood and loss of interest
• Cognitive Changes: Memory problems and difficulty concentrating
• Peripheral Neuropathy: Numbness or tingling sensations

Gastrointestinal System

GI manifestations include:

• Nausea and Vomiting: Related to hypercalcemia
• Constipation: Reduced gut motility
• Abdominal Pain: Discomfort from various causes
• Loss of Appetite: Reduced desire to eat
• Peptic Ulcer Disease: Increased risk, partly from increased gastric acid

Primary hyperparathyroidism (PHPT) results from intrinsic parathyroid gland dysfunction. The most common cause is a solitary adenoma (80-85% of cases), followed by parathyroid hyperplasia (10-15%) affecting multiple glands, and rarely parathyroid carcinoma (less than 1%).

Sporadic PHPT typically presents in adults over 50, with peak incidence in the 60s. It affects women three times more frequently than men. Most cases are discovered incidentally through routine blood testing showing elevated calcium.

Familial forms exist, including Multiple Endocrine Neoplasia type 1 (MEN1), MEN2A, and familial isolated hyperparathyroidism. These hereditary conditions require comprehensive genetic evaluation and family screening.

Secondary hyperparathyroidism develops as a compensatory response to chronic hypocalcemia. The most common cause is chronic kidney disease (CKD), which impairs vitamin D activation and reduces phosphate excretion, both lowering serum calcium. The parathyroid glands hypertrophy in response to chronic stimulation.

Vitamin D deficiency from malabsorption, nutritional deficiency, or lack of sunlight exposure represents another significant cause. Long-term secondary hyperparathyroidism can progress to tertiary hyperparathyroidism, where glands become autonomous.

Parathyroid Adenoma

The most common cause of primary hyperparathyroidism, parathyroid adenomas are benign tumors arising from chief cells. These growths function autonomously—they produce PTH regardless of calcium levels, creating the fundamental dysfunction of primary hyperparathyroidism.

Adenomas may be microadenomas (less than 1 cm) or macroadenomas (larger). Most are sporadic, occurring without clear genetic predisposition. The GNAS gene mutation found in some adenomas activates the calcium-sensing receptor pathway inappropriately.

Parathyroid Hyperplasia

Diffuse enlargement of all four parathyroid glands accounts for 10-15% of primary hyperparathyroidism. This may occur sporadically or as part of hereditary syndromes. Hyperplastic glands show increased cell proliferation without forming discrete tumors.

Parathyroid Carcinoma

Rare but serious, parathyroid carcinoma accounts for less than 1% of cases. These malignant tumors are locally invasive and may metastasize. They typically present with very high calcium levels and palpable neck masses.

• Genetic Susceptibility: Family history increases risk
• Previous Neck Radiation: Therapeutic radiation for head/neck cancers
• Chronic Kidney Disease: Leads to secondary/tertiary types
• Vitamin D Deficiency: Contributes to secondary hyperparathyroidism
• Lithium Use: Long-term lithium therapy can cause hyperparathyroidism

• Age: Risk increases significantly after age 50
• Gender: Women affected 3x more frequently than men
• Genetic Conditions: MEN1, MEN2A, familial hyperparathyroidism
• Family History: First-degree relative with hyperparathyroidism

• Vitamin D Deficiency: Correctable with supplementation
• Chronic Kidney Disease: Manageable with appropriate treatment
• Lithium Exposure: May need medication review
• Inadequate Calcium Intake: But excessive supplementation also problematic

• Postmenopausal women
• Individuals with chronic kidney disease
• Patients with vitamin D deficiency (common in Gulf region due to limited sun exposure through traditional dress)
• Those with family history of endocrine tumors

Many patients with primary hyperparathyroidism present with no symptoms—the condition is discovered through routine blood testing. When symptoms occur, they typically involve multiple systems:

Neuromuscular Symptoms

• Persistent, unexplained fatigue not relieved by rest
• Generalized muscle weakness, particularly in proximal muscles
• Depression and mood changes
• Memory difficulties and trouble concentrating
• Sleep disturbances

Skeletal Symptoms

• Bone pain, particularly in weight-bearing joints
• Osteoporosis demonstrable on bone density testing
• Fractures occurring with minimal trauma
• Loss of height from vertebral compression

Renal Symptoms

• Recurrent kidney stones
• Flank pain during stone passage
• Increased urination (polyuria)
• Frequent urinary tract infections

Gastrointestinal Symptoms

• Nausea and reduced appetite
• Constipation
• Abdominal pain
• Weight loss

Up to 80% of patients with primary hyperparathyroidism report no classic symptoms at diagnosis. These asymptomatic cases are typically identified through incidental finding of hypercalcemia on routine testing. Even without symptoms, these patients may have subclinical complications affecting bones and kidneys.

• Kidney Stones: Calcium-based stones in 15-20% of patients
• Nephrocalcinosis: Calcium deposition in kidney tissue
• Chronic Kidney Disease: Progressive loss of function
• Renal Colic: Severe pain from stone passage

• Hypertension in 30-50% of patients
• Increased cardiovascular mortality
• Valvular calcification
• Left ventricular hypertrophy

• Peptic ulcer disease
• Pancreatitis
• Gout and pseudogout
• Depression and cognitive dysfunction

At Healers Clinic, our comprehensive assessment includes:

Symptom Assessment: Detailed questioning about fatigue, bone pain, kidney stones, depression, memory problems, nausea, and urination changes. We explore symptom onset, duration, and progression.

Medical History: Previous neck surgeries, radiation therapy, kidney disease, vitamin D status, and thyroid conditions all provide important context.

Medication Review: Current medications including lithium, thiazide diuretics, bisphosphonates, and supplements are reviewed.

Family History: Particularly important given hereditary forms of hyperparathyroidism and associated syndromes.

Physical examination may be entirely normal in primary hyperparathyroidism. Findings that may be present include:

• Palpable neck mass (suggests carcinoma)
• Evidence of bone deformity
• Hypertension
• Evidence of prior kidney stones

Our integrative assessment incorporates:

• Conventional laboratory testing
• Advanced hormone panel including PTH, calcium, phosphorus, vitamin D
• Ayurvedic constitutional assessment (Prakriti analysis)
• Homeopathic case-taking for individualized remedy selection
• NLS bioenergetic screening for comprehensive evaluation

Diagnosis requires:

1. Elevated or inappropriately normal PTH with elevated serum calcium
2. Exclusion of other causes of hypercalcemia
3. Assessment of end-organ effects

Neck Ultrasound: Identifies enlarged glands, distinguishes solid from cystic lesions, guides fine-needle aspiration if needed.

Sestamibi Scan: Nuclear medicine scan that localizes overactive parathyroid tissue with high accuracy, particularly useful for preoperative planning.

4D-CT Scan: Advanced imaging providing detailed anatomical localization of abnormal glands.

• Dual-energy X-ray Absorptiometry (DXA): Measures bone mineral density
• Kidney Ultrasound: Detects stones, nephrocalcinosis
• eGFR: Assesses kidney function

The diagnostic pathway systematically excludes other causes of hypercalcemia before confirming primary hyperparathyroidism. This involves measuring PTH in the setting of hypercalcemia—elevated or inappropriately normal PTH confirms the diagnosis.

Parathyroidectomy: Surgical removal of overactive parathyroid tissue is the definitive treatment for primary hyperparathyroidism. Cure rates exceed 95% with experienced surgeons.

Surgical Indications:

• Serum calcium >1 mg/dL above upper limit of normal
• Bone disease (osteoporosis on DXA)
• Kidney stones or nephrocalcinosis
• Reduced kidney function (eGFR <60)
• Symptomatic disease
• Patient preference

Surgical Approaches:

• Minimally Invasive Parathyroidectomy (MIP): Small incision with targeted gland removal; preferred for localized disease
• Bilateral Neck Exploration: Traditional approach for extensive disease or uncertain localization

For patients who cannot undergo surgery or choose medical management:

Calcimimetics: Cinacalcet and etelcalcetide mimic calcium to suppress PTH secretion. These medications effectively lower calcium and PTH levels but do not cure the underlying condition.

Bisphosphonates: Alendronate and other bisphosphonates reduce bone resorption and can improve bone density in hyperparathyroidism.

Vitamin D Supplementation: Correcting deficiency helps manage secondary hyperparathyroidism. Must be medically supervised to avoid worsening hypercalcemia.

The choice between surgery and medical management depends on:

• Severity of hypercalcemia
• Presence of symptoms
• End-organ complications
• Patient age and surgical risk
• Patient preference

Classical homeopathic prescribing addresses individual symptom patterns:

Common Remedies:

• Calcarea carbonica: For chilliness, fatigue, osteoporosis, anxiety
• Calcarea phosphorica: For bone pain, weak bones, growing pains
• Silicea: For suppurative tendencies, fistula formation
• Phosphorus: For bleeding tendencies, anxiety, burning pains
• Sulfur: For warm patients, skin symptoms, intellectual fatigue

Homeopathic treatment supports overall wellbeing while conventional treatment addresses the underlying condition.

Ayurvedic management addresses the constitutional aspects:

Dosha Assessment: Hyperparathyroidism relates to Vata-Kapha imbalance affecting Asthi (bone) and Mutravaha Srotas (urinary system).

Dietary Recommendations:

• Warm, cooked, easily digestible foods
• Adequate calcium through natural sources
• Avoid excessive raw foods
• Appropriate hydration

Herbal Support:

• Ashoka (Saraca indica): Supports bone health
• Lakshmana (Solanum nigrum): Traditional use for calcium metabolism
• Guggulu (Commiphora mukul): Supports bone and joint health

Panchakarma: May be indicated for constitutional balancing in appropriate patients

Targeted nutrient support addresses deficiencies:

• Vitamin D: Corrects deficiency, supports calcium metabolism
• Magnesium: Required for PTH function and bone health
• B-Complex Vitamins: Support energy and nervous system
• Calcium: If dietary intake inadequate (post-surgical)

Comprehensive supportive care includes:

• Nutritional counseling for bone health
• Lifestyle modification guidance
• Stress management
• Exercise prescription for bone strengthening

Hydration: Drink 2-3 liters of water daily to reduce kidney stone risk. Adequate fluid intake dilutes urine calcium concentration.

Dietary Balance:

• Moderate calcium intake (1000-1200 mg daily from all sources)
• Adequate but not excessive vitamin D
• Limit sodium which increases calcium excretion
• Moderate animal protein intake

Exercise: Weight-bearing exercise supports bone health. Aim for 30 minutes most days including resistance training.

Medication Adherence: Take prescribed medications consistently. Report any side effects to healthcare providers.

Symptom Monitoring: Keep track of symptoms that may indicate worsening:

• Increased bone pain
• New or worsening kidney stones
• Increasing fatigue
• Depression or cognitive changes

Contact your healthcare provider if:

• Symptoms significantly worsen
• New symptoms develop
• Signs of kidney stones (severe flank pain, blood in urine)
• Medication side effects occur
• Surgery is being considered

Primary hyperparathyroidism cannot be reliably prevented, as most cases arise from sporadic genetic mutations. However:

• Maintain Adequate Calcium Intake: Prevents compensatory secondary hyperparathyroidism
• Ensure Vitamin D Sufficiency: Supports normal calcium metabolism
• Avoid Neck Radiation When Possible: Therapeutic radiation is a known risk factor

For those with diagnosed hyperparathyroidism:

• Regular Monitoring: Track calcium, PTH, kidney function
• Bone Density Monitoring: Annual DXA scans
• Kidney Monitoring: Annual renal ultrasound if stones have occurred
• Early Intervention: Treat before significant complications develop

With appropriate treatment, hyperparathyroidism has excellent outcomes:

• Surgery: 95%+ cure rate with normalization of calcium and PTH
• Medical Management: Effective symptom control in most patients
• Complications: Often reversible with treatment, especially if caught early

• Post-Surgery: Calcium normalizes within 24-48 hours
• Symptom Improvement: Most patients notice improvement within weeks
• Bone Recovery: Bone density improvements measurable over 1-2 years
• Kidney Function: May improve if not severely damaged

• Timing of Treatment: Earlier treatment leads to better outcomes
• Complication Severity: Pre-existing kidney damage may be irreversible
• Surgical Success: Experience of surgeon matters significantly
• Follow-up Adherence: Ongoing monitoring prevents recurrence

Q: Does hyperparathyroidism always require surgery? A: Not always. Asymptomatic patients with mild disease may be monitored. Surgery is recommended for symptomatic patients, those with calcium significantly above normal, bone disease, kidney stones, or reduced kidney function.

Q: What are the risks of not treating hyperparathyroidism? A: Untreated hyperparathyroidism can lead to osteoporosis and fractures, kidney stones and kidney damage, cardiovascular disease, worsening fatigue and depression, and in rare cases, severe hypercalcemia crisis.

Q: How is hyperparathyroidism diagnosed? A: Diagnosis requires blood tests showing elevated serum calcium with elevated or inappropriately normal parathyroid hormone (PTH). Additional tests assess vitamin D status, kidney function, and end-organ effects.

Q: What is minimally invasive parathyroidectomy? A: This advanced surgical technique uses a small incision and precise gland localization to remove only the overactive gland(s). It offers faster recovery, less pain, and minimal scarring compared to traditional surgery.

Q: How long is recovery after parathyroid surgery? A: Most patients recover within 1-2 weeks. Temporary low calcium is common and treated with supplements. Most feel significantly better within weeks of surgery.

Q: Can hyperparathyroidism recur after surgery? A: Recurrence occurs in approximately 5-10% of cases over many years. Long-term follow-up monitoring is recommended.

Q: What is the difference between primary and secondary hyperparathyroidism? A: Primary hyperparathyroidism arises from intrinsic parathyroid gland disease. Secondary hyperparathyroidism results from another condition (typically kidney disease or vitamin D deficiency) causing chronic parathyroid stimulation.

Q: Can diet help manage hyperparathyroidism? A: While diet cannot cure hyperparathyroidism, staying well-hydrated, maintaining moderate calcium intake, and ensuring adequate vitamin D can support management. Surgery remains definitive treatment.

Q: How does hyperparathyroidism affect pregnancy? A: Untreated hyperparathyroidism in pregnancy carries risks including preeclampsia, miscarriage, and neonatal hypocalcemia. Management requires close coordination between endocrinologist and obstetrician.

Q: Is hyperparathyroidism hereditary? A: Most cases are sporadic. However, hereditary forms exist including Multiple Endocrine Neoplasia (MEN) syndromes. Family screening may be recommended in appropriate cases.

Last Updated: March 2026 Healers Clinic - Transformative Integrative Healthcare Serving patients in Dubai, UAE and the GCC region since 2016 Phone: +971 56 274 1787 Location: St. 15, Al Wasl Road, Jumeira 2, Dubai